Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in . gov or . mil VSports app下载. Before sharing sensitive information, make sure you’re on a federal government site. .

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. V体育官网.

. 2009 Mar 12;458(7235):206-10.
doi: 10.1038/nature07662. Epub 2008 Dec 10.

V体育官网 - Enhancing SIV-specific immunity in vivo by PD-1 blockade

Vijayakumar Velu  1 , Kehmia Titanji, Baogong Zhu, Sajid Husain, Annette Pladevega, Lilin Lai, Thomas H Vanderford, Lakshmi Chennareddi, Guido Silvestri, Gordon J Freeman, Rafi Ahmed, Rama Rao Amara
Affiliations

Enhancing SIV-specific immunity in vivo by PD-1 blockade

Vijayakumar Velu et al. Nature. .

Abstract

Chronic immunodeficiency virus infections are characterized by dysfunctional cellular and humoral antiviral immune responses. As such, immune modulatory therapies that enhance and/or restore the function of virus-specific immunity may protect from disease progression. Here we investigate the safety and immune restoration potential of blockade of the co-inhibitory receptor programmed death 1 (PD-1) during chronic simian immunodeficiency virus (SIV) infection in macaques. We demonstrate that PD-1 blockade using an antibody to PD-1 is well tolerated and results in rapid expansion of virus-specific CD8 T cells with improved functional quality. This enhanced T-cell immunity was seen in the blood and also in the gut, a major reservoir of SIV infection VSports手机版. PD-1 blockade also resulted in proliferation of memory B cells and increases in SIV envelope-specific antibody. These improved immune responses were associated with significant reductions in plasma viral load and also prolonged the survival of SIV-infected macaques. Blockade was effective during the early (week 10) as well as late ( approximately week 90) phases of chronic infection even under conditions of severe lymphopenia. These results demonstrate enhancement of both cellular and humoral immune responses during a pathogenic immunodeficiency virus infection by blocking a single inhibitory pathway and identify a novel therapeutic approach for control of human immunodeficiency virus infections. .

PubMed Disclaimer

Figures

Figure 1
Figure 1. In vivo PD-1 blockade during chronic SIV infection increases the Gag CM9-specific CD8 T cells with improved functional quality in both blood and gut
a) Representative FACS plots for the macaque RRk10. The magnitude and phenotype of Gag CM9-tetramer positive CD8 T cells in blood (b) and gut (colorectal mucosal tissue) (c). Representative FACS plots are shown on the left and summary for all Mamu A*01 positive animals is shown on the right. Numbers on the FACS plots represent the frequency of tetramer positive cells as a percent of total CD8 T cells. Arrows and vertical dotted lines indicate anti-PD-1 Ab or control Ab treatment.
Figure 2
Figure 2. In vivo PD-1 blockade during chronic SIV infection increases the polyfunctional virus-specific CD8 T cells
a) Frequency of Gag-specific cytokine secreting CD8 T cells as a percent of total CD8 T cells. Representative FACS plots are shown on the left and summary for the group is shown on the right. Arrows and vertical dotted lines indicate anti-PD-1 Ab or control Ab treatment. Green lines represent anti-PD-1 Ab treated macaques and red lines represent control Ab treated macaques. b) Cytokine co-expression subsets expressed as a percent of total cytokine positive cells. Mean for the group is shown.
Figure 3
Figure 3. In vivo PD-1 blockade during chronic SIV infection enhances SIV-specific humoral immunity
a) Expression of PD-1 on memory (CD20+CD27+CD21-) and naïve (CD20+CD27-CD21+) B cells in blood following SIV infection and prior to in vivo PD-1 blockade. b) Titers of anti-SIV Env binding Ab in serum following blockade. c) Ki-67 expression (marker for proliferation) on memory and naïve B cells following blockade. Numbers on the FACS plots represent Ki-67 positive cells as a percent of respective total cells. Macaques RAf11 and RJd11 were treated simultaneously with anti-PD-1 Ab and anti-retroviral therapy at 22 weeks post SIV infection.
Figure 4
Figure 4. In vivo PD-1 blockade reduces plasma viremia and prolongs survival of SIV-infected macaques
Plasma viral load in a) macaques treated with anti-PD-1 Ab during the early chronic phase b) macaques treated with anti-PD-1 Ab during the late chronic phase and c) macaques treated with control Ab during the early/late chronic phase of SIV infection. d) Fold reduction in plasma viral load between day 0 and day 28 (early chronic study) or day 0 and day 21 (late chronic study). e) Survival of SIV-infected macaques following PD-1 blockade. =, death of animal.
None
See this image and copyright information in PMC

Comment in

References

    1. Wherry EJ, et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity. 2007;27:670–684. - PubMed
    1. Klenerman P, Hill A. T cells and viral persistence: lessons from diverse infections. Nat Immunol. 2005;6:873–879. - PubMed
    1. Zajac AJ, et al. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med. 1998;188:2205–2213. see comments. - PMC - PubMed
    1. Gallimore A, et al. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J Exp Med. 1998;187:1383–1393. - PMC - PubMed
    1. Letvin NL, Walker BD. Immunopathogenesis and immunotherapy in AIDS virus infections. Nat Med. 2003;9:861–866. - PubMed (V体育平台登录)

Publication types

"VSports app下载" MeSH terms

Associated data